Status:
COMPLETED
A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Bile Duct Carcinoma
Gallbladder Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial compares the effect of LMA Gastro, a dual channel supraglottic airway (SGA) device, to oxygenation with standard nasal cannula for endoscopic retrograde cholangiopancreatography (E...
Detailed Description
PRIMARY OBJECTIVE: I. To compare the incidence of desaturation (oxygen saturation \[SpO2\] \< 90%) between patients undergoing ERCP with LMA Gastro versus (vs) standard nasal cannula. SECONDARY OBJE...
Eligibility Criteria
Inclusion
- Adult patients (\>= 18 years old) undergoing ERCP
Exclusion
- Patients with propofol allergy
- Patients at increased aspiration risk
- Patients with abnormal head/neck pathology preventing LMA Gastro placement
- Patients with surgical or radiation treatment to the head/neck making LMA Gastro placement difficult
- Patient with known difficult airway requiring advanced intubation equipment (with the exception of the video-laryngoscope) in the past
- Esophagectomy patients
- Patients already intubated upon arrival to endoscopy suite
- Patients undergoing endoscopic ultrasound (EUS)
- Patients with body mass index (BMI) \>= 35 kg/m\^2
- Patients with hypoxemia (SpO2 \< 94% on room air or on home oxygen)
- American Society of Anesthesiology (ASA) Physical Status IV-V
Key Trial Info
Start Date :
February 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 4 2023
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04740164
Start Date
February 24 2021
End Date
May 4 2023
Last Update
November 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030